»ï¼º¼¿ïº´¿ø The 16th SMC Vascular Symposium, 2023 : 2023-05-27
±³À°ÀÏÀÚ : 2023-05-27
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç
±³À°ÁÖÁ¦ : The 16th SMC Vascular Symposium, 2023
ÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Ç÷°ü¿Ü°ú
´ã´çÀÚ : ÀåÇý¼÷
¿¬¶ôó : 02-3410-3792
À̸ÞÀÏ : hs0129.jang@samsung.com
±³À°Á¾·ù : ÀÇ»çÇÐ
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í °³¿øÀÇ,Àü¹®ÀÇ : »çÀüµî·Ï 30,000¿ø / ´çÀϵî·Ï : 50,000¿øÀü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:00~09:05 Case presentation °ÁöÈñ(ÀÎÇϴ뺴¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:05~09:15 Differentiating leg edema from venous disease ȲÁöÇý(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:15~09:25 Indication and ethics in varicose vein treatment ¾È»óÇö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:25~09:35 Thermal vs. non-thermal ablation. Who won? What¡¯s better? ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:35~09:45 Treatment strategy for recanalized saphenous vein: When and How ÇÑ¿µÁø(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:45~09:55 Treatment strategy for chronic venous insufficiency and leg ulceration ±è»óµ¿(ÀÎõ¼º¸ðº´¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 09:55~10:00 Case wrap up °ÁöÈñ(ÀÎÇϴ뺴¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:00~10:20 Panel Discussion ( )
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:20~10:40 Tips for carotid endarterectomy : Base on my 30 years experiences (1994-2023) ±èµ¿ÀÍ(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:40~10:50 Coffee break ( )
±âŸ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:50~10:55 Case presentation ¾ç½Å¼®(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 10:55~11:05 How to screen for high-risk ACS: imaging surveillance ÃÖ¿¬Çö(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:05~11:15 Best medical treatment: revascularization will be no longer needed ±èÇüÁØ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:15~11:25 Debate: When to CEA À±¿ì¼º(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:25~11:35 Debate: When to CAS ¼¿ì±Ù(»ï¼º¼¿ïº´¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:35~11:40 Case wrap up ¾ç½Å¼®(»ï¼º¼¿ïº´¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 11:40~12:00 Panel Discussion ( )
½Ä»ç 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 12:00~13:00 Lunch ( )
±âŸ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:00~13:05 Case presentation ±èÇü¼ö(Àϻ꺴¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:05~13:15 Surgery vs endovascular therapy: is the BEST-CLI trial going to change clinical practice? ±èÇü±â(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:15~13:25 How to size lower extremity arteries accurately using IVUS: better sizing of DCB? °í¿µ±¹(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:25~13:35 Atherectomy: Which is the best for vessel preparation? ¹Ú±¤º¸(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:35~13:45 How to treat SFA ISR CTO? Á¦È¯ÁØ(¼¿ï´ëº´¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:45~13:50 Case wrap up ±èÇü¼ö(Àϻ꺴¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 13:50~14:10 Panel Discussion ( )
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:10~14:40 Real-world practice of in situ or NRT distal leg artery bypass in CLTI patients Dr. Taku Kokubo(Edogawa Hospital Tokyo Japan)
ÈÞ½Ä 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:40~14:50 Coffee break ( )
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 14:50~15:00 Antithrombotic therapy after revascularization: dual antiplatelet vs dual pathway inhibition À±¿µÁø(¿øÁÖ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:00~15:10 Lipid-lowering therapy: recent advances (ezetimibe, PCSK9 inhibitors, inclisiran, bempedoic acid) ¿øÈ£¿¬(Á߾Ӵ뺴¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:10~15:20 Emerging glucose-lowering therapies: a guide for vascular specialist ÀÌÀºÁ¤(°ºÏ»ï¼ºº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:20~15:30 Exercise therapy: evidence and real-world practice ÀÌÁ¾¿µ(°ºÏ»ï¼ºº´¿ø)
Åä·Ð 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:30~15:50 Panel Discussion ( )
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 15:50~16:00 Acute limb ischemia: role of thrombolytics and open balloon catheter thrombectomy ±ÇÁر³(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:00~16:10 Percutaneous deep venous arterialization ±èÁø¿ì(¾ÆÁִ뺴¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:10~16:20 Occlusion of IVC, SVC, or porto-mesenteric Á¤¼ö·Ã(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:20~16:30 Visceral artery dissection: always benign? ¹ÚÅñÔ(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:30~16:40 Lymphatic intervention: chylothorax or chylous ascites Çöµ¿È£(»ï¼º¼¿ïº´¿ø)
±³À°½Ã°£ 05¿ù 27ÀÏ »ï¼º¼¿ïº´¿ø º»°ü B1 ´ë°´ç 16:40~16:50 CT-guided peripheral arterial intervention ÀÌöÇö(°è¸í´ëµ¿»êº´¿ø)